IP Verse

Human Anti-Il-23 Antibodies, Compositions, Method And Uses

PatentPatent Analysis

EP3219328

JANSSEN BIOTECH
Application Number
EP17156111A
Filing Date
Dec 28, 2006
Status
Revoked
Mar 19, 2021
Grant Date
Jun 17, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3883606B9
EP3880824B1
EP2970980B2

Bibliography

The patent EP3219328B1 was granted to Janssen Biotech on Jun 17, 2020 following the initial filing on Dec 28, 2006 under the application number EP17156111A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ABBVIEMar 17, 2021DEEMED NOT TO HAVE BEEN FILED
BOEHRINGER INGELHEIM PHARMAMar 17, 2021DEEMED NOT TO HAVE BEEN FILED

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents